TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

Why Tempus AI Stock Is Trading Higher On Monday?

Benzinga Logo Benzinga By Lekha Gupta
Why Tempus AI Stock Is Trading Higher On Monday?

Tempus AI (NASDAQ: TEM) stock rose on Monday following the release of preliminary fourth-quarter and full-year 2025 results showing $1.27 billion in revenue with 83% year-over-year growth. The company also announced two major strategic partnerships: a multi-year collaboration with NYU Langone Health to advance cancer care through molecular profiling, and a contract with Northwestern Medicine to broaden access to genomic testing for cancer patients.

Insights
BIDU   negative

Slipped 2.50% despite beating earnings, due to an 18% year-over-year drop in online marketing revenue


TEM   positive

Strong financial results with 83% YoY revenue growth to $1.27 billion, significant organic growth of 30%, and two major strategic partnerships with leading healthcare institutions that expand market reach and validate the company's cancer testing capabilities. Stock price increased 3.86% on the announcement.